KALV
KalVista Pharmaceuticals, Inc. · Healthcare
Director Albert Cha sold $189K of KalVista Pharmaceuticals, Inc.
Sold$189,050
$10.50Price
18,000Shares
−100%Stake
What KALV did after the filing
- The stock from Thu, Sep 14 open, $10.07
- −20.1%
- S&P 500, same days
- −7.8%
Measured over 30 trading days, to the Oct 26 close.
Traded Mon, Sep 11. Filed Wed, Sep 13, 4:29 PM ET, after the close. Returns use the Sep 14 open and the Oct 26 close. Not investment advice.